Fundamental Valuation, page-5

First 5 Last

Share
Profile

Follow
Exised

6,277 Posts.

2966

15/02/21

12:41

Post #: 50992537
Share

Originally posted by p477on: ↑

Just wondering what people are thinking about this stock. Any reason that it is trading at such a discount? Is it simply the production downgrade? Or because markets are bearish on the gold price? Do people have a problem with management?I’m convinced that they are going to be a great long-term bet. Soon they will lock in financing for KOTH. Gold miners typically trade 5-8x EV/EBITDA, RED5 are currently at 6.7x EV/EBITDA, even with their growth story. The development of their mine is highly likely at post-tax IRR of 64% and as such stock is not priced appropriately. They have a backable feasibility study and are already developing mine expansions. Net debt is ($70m).

If they are at year 1 production, 3x current production, in mid-CY22. This will move their EBITDA from ~$44m LTM, to ~$190 run-rate conservatively as the new mine will have a much lower AISC to mine and some scale effects. If you build some scenarios around the gold price for this and I’m still pretty confident. In a world where they don’t pull off mine expansion it tanks but in the world where they achieve the mine build-out I see a EBITDA multiple at say todays 7x and you can do the math on TSR (5-6x in this scenario). So look I think there’s a lot of room to move here for the gold price downward, but I kind of believe I will do at least ok. Seems like a good story right?

Figure1: AUD gold prices could come off 15% and project still has a pre-tax IRR of38%

Figure2: Today St Barbara has a 3x market cap on RED, and Westgold a 2.3x

Expand

Patience, this pretty much sums up why I'm invested in RED. Post #: 45916194
It is not a big holding but enough to put a smile on my face when we get KOTH up and running

RED Price at posting: 22.5¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

Failure to report prompts ASX to impose multiple company suspensions

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

IRE

Iress runs 'hot' for Wealth Within's stock tips

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia